Notably, the expression of NXPH4 was significantly higher in T24GEM-R and 5637GEM-R cells than that in parental cells (Figure 5B), which was consistent with the elevated NXPH4 expression in bladder cancer tissues of patients resistant to chemotherapy with gemcitabine. The gene discussed is NXPH4; the disease is urinary bladder carcinoma.